Click on image to view larger version.

Figure 1 Effect of SES Versus BMS on Subsequent Death or Survival Free of Infarction

An analysis of 14 trials in 4,958 patients undergoing percutaneous coronary intervention with either sirolimus-eluting stents (SES) or bare-metal stents (BMS). There is no statistically significant difference in subsequent mortality (A) or survival free of myocardial infarction (B). Used with permission from Kastrati et al. (12).